We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
The European Centre for Disease Prevention and Control continues to report shigellosis in travellers returning to Europe and the USA from Cape Verde.
As of 16 February 2023, there have been 258 cases of shigellosis in total reported from the following countries: United Kingdom (95 cases), the Netherlands (47 cases), Sweden (42 cases), France (31 cases), Belgium (14 cases), Finland (9 cases), Germany (5 cases), Czech Republic (4 cases), Denmark (4 cases), the United States (4 cases), Portugal (2 cases) and Norway (1 case).
Shigellosis is a bacterial gut infection that can result in dysentery (bloody diarrhoea). It is spread from person-to-person through the faecal-oral route, mainly through contaminated food and water.
Shigella bacteria are highly infectious, it only takes a small amount of Shigella to make someone sick. Illness is usually short lived (4-7 days) and can resolve without treatment. Severe cases may require medical treatment.
There is no vaccine available against Shigellosis.
All travellers, irrespective of destination should be advised to seek medical advice if they develop symptoms, which may include:
All travellers should be advised to practice effective hand hygiene and food and water precautions. This includes:
Travellers returning home with symptoms of Shigellosis should be advised to:
For further information see: